Effect of isoflavone supplementation on menopausal symptoms: a systematic review and meta-analysis of randomized controlled trials
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Complementary and alternative medicines can be used to alleviate climacteric symptoms that significantly affect the quality of life of postmenopausal women. Isoflavones are the most common plant-based therapies for postmenopausal changes, but the results of previous studies have been controversial. MATERIALS/METHODS: To investigate whether isoflavones would affect menopausal symptoms as well as ovarian hormones, we performed a systematic review and meta-analysis. The PubMed and EMBASE databases were used to perform the systematic search. Included studies were limited to randomized controlled trials (RCTs) assessing the impact of isoflavone supplementation on menopausal symptoms. RESULTS: Eleven studies were included for the final quantitative assessment. Isoflavone intervention was varied between 49.3 and 135 mg of isoflavones per day for 12 wk–2 yrs. The meta-analysis showed that supplementation of isoflavones significantly increased the estradiol levels (standardized mean difference [SMD] = 0.615, P = 0.035) and Kupperman index (SMD = 3.121, P = 0.003) but had no significant effect on hot flashes, follicle-stimulating hormone, and luteinizing hormone. However, both estradiol and the Kupperman index showed significant heterogeneity among studies (I2 = 94.7%, P < 0.001 and I2 = 98.1%, P < 0.001, respectively). CONCLUSIONS: Although the results showed a significant SMD in estradiol and the Kupperman index, the results should be interpreted with caution due to the high heterogeneity. Further validation with a larger RCT will be necessary. Overall, isoflavone supplementation has distinct effects on the climacteric symptoms and hormonal changes in postmenopausal women.
Abstract
BACKGROUND/OBJECTIVES: Complementary and alternative medicines can be used to alleviate climacteric symptoms that significantly affect the quality of life of postmenopausal women. Isoflavones are the most common plant-based therapies for postmenopausal changes, but the results of previous studies have been controversial. MATERIALS/METHODS: To investigate whether isoflavones would affect menopausal symptoms as well as ovarian hormones, we performed a systematic review and meta-analysis. The PubMed and EMBASE databases were used to perform the systematic search. Included studies were limited to randomized controlled trials (RCTs) assessing the impact of isoflavone supplementation on menopausal symptoms. RESULTS: Eleven studies were included for the final quantitative assessment. Isoflavone intervention was varied between 49.3 and 135 mg of isoflavones per day for 12 wk–2 yrs. The meta-analysis showed that supplementation of isoflavones significantly increased the estradiol levels (standardized mean difference [SMD] = 0.615, P = 0.035) and Kupperman index (SMD = 3.121, P = 0.003) but had no significant effect on hot flashes, follicle-stimulating hormone, and luteinizing hormone. However, both estradiol and the Kupperman index showed significant heterogeneity among studies (I2 = 94.7%, P < 0.001 and I2 = 98.1%, P < 0.001, respectively). CONCLUSIONS: Although the results showed a significant SMD in estradiol and the Kupperman index, the results should be interpreted with caution due to the high heterogeneity. Further validation with a larger RCT will be necessary. Overall, isoflavone supplementation has distinct effects on the climacteric symptoms and hormonal changes in postmenopausal women.
참고문헌 (49)
- Burger HG, "Hormonal changes in the menopause transition", Recent Prog Horm Res, 57, pp.257~275 (2002)
- Barnabei VM, "Menopausal symptoms in older women and the effects of treatment with hormone therapy", Obstet Gynecol, 100, pp.1209~1218 (2002)
- Hulley S, "Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen", progestin Replacement Study follow-up (HERS II), 2002, pp.288, 58~66
- Nachtigall LE, "Estrogen replacement therapy II : a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems", Obstet Gynecol, 54, pp.74~79 (1979)
- Cos P, "Phytoestrogens : recent developments", Planta Med, 69, pp.589~599 (2003)
- Moutsatsou P, "The spectrum of phytoestrogens in nature: our knowledge is expanding", Hormones (Athens), 6, pp.173~193 (2007)
- Pilšáková L, "The physiological actions of isoflavone phytoestrogens", Physiol Res, 59, pp.651~664 (2010)
- Ewies AA, "Phytoestrogens in the management of the menopause : up-to-date", Obstet Gynecol Surv, 57, pp.306~313 (2002)
- Franco OH, "Use of plant-based therapies and menopausal symptoms : a systematic review and meta-analysis", JAMA, 315, pp.2554~2563 (2016)
- Chen MN, "Efficacy of phytoestrogens for menopausal symptoms : a meta-analysis and systematic review", Climacteric, 18, pp.260~269 (2015)
- Higgins JP, "Cochrane Handbook for Systematic Reviews of Interventions", pp.205~228 (2019), The Cochrane Collaboration
- Higgins JP, "Quantifying heterogeneity in a meta-analysis", Stat Med, 21, pp.1539~1558 (2002)
- Cochran WG, "The combination of estimates from different experiments", Biometrics, 10, pp.101~129 (1954)
- Page MJ, "Cochrane Handbook for Systematic Reviews of Interventions", pp.349~374 (2019), The Cochrane Collaboration
- Egger M, "Bias in meta-analysis detected by a simple, graphical test", BMJ, 315, pp.629~634 (1997)
- Harrer M, "Doing Meta-Analysis with R: a Hands-on Guide", pp.2021, Chapman and Hall
- Han KK, "Benefits of soy isoflavone therapeutic regimen on menopausal symptoms", Obstet Gynecol, 99, pp.389~394 (2002)
- Steinberg FM, "Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women", Am J Clin Nutr, 93, pp.356~367 (2011)
- Maskarinec G, "Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women", Cancer Epidemiol Biomarkers Prev, 13, pp.1736~1744 (2004)
- 이한송이, "Effect of soy isoflavones supplement on climacteric symptoms, bone biomarkers, and quality of life in Korean postmenopausal women: a randomized clinical trial", Nutrition Research and Practice, 11(3), pp.223~231 (2017), 한국영양학회
- Sapbamrer R, "Effects of dietary traditional fermented soybean on reproductive hormones, lipids, and glucose among postmenopausal women in northern Thailand", Asia Pac J Clin Nutr, 22, pp.222~228 (2013)
- Jou HJ, "Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones", Int J Gynaecol Obstet, 102, pp.44~49 (2008)
- Radhakrishnan G, "Evaluation of isoflavone rich soy protein supplementation for postmenopausal therapy", Pak J Nutr, 8, pp.1009~1017 (2009)
- St Germain A, "Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment", Menopause, 8, pp.17~26 (2001)
- Liu ZM, "Effects of soy protein and isoflavones on glycemic control and insulin sensitivity : a 6-mo double-blind, randomized, placebo-controlled trial in postmenopausal Chinese women with prediabetes or untreated early diabetes", Am J Clin Nutr, 91, pp.1394~1401 (2010)
- Llaneza P, "Soy isoflavones improve insulin sensitivity without changing serum leptin among postmenopausal women", Climacteric, 15, pp.611~620 (2012)
- Cheng G, "Isoflavone treatment for acute menopausal symptoms", Menopause, 14, pp.468~473 (2007)
- Liu ZM, "Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women", Menopause, 21, pp.653~660 (2014)
- Lambert MN, "Combined red clover isoflavones and probiotics potently reduce menopausal vasomotor symptoms", PLoS One, 12, pp.e0176590~ (2017)
- Hooper L, "Effects of soy protein and isoflavones on circulating hormone concentrations in pre-and post-menopausal women : a systematic review and meta-analysis", Hum Reprod Update, 15, pp.423~440 (2009)
- Fritz H, "Soy, red clover, and isoflavones and breast cancer : a systematic review", PLoS One, 8, pp.e81968~ (2013)
- Kronenberg F, "Complementary and alternative medicine for menopausal symptoms : a review of randomized, controlled trials", Ann Intern Med, 137, pp.805~813 (2002)
- Haines CJ, "Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens", medroxyprogesterone acetate : the Pan-Asia Menopause(PAM)study, 2005, pp.52, 264~276
- Shea JL, "Parsing the ageing Asian woman : symptom results from the China study of midlife women", Maturitas, 55, pp.36~50 (2006)
- Clarkson TB, "The role of soy isoflavones in menopausal health: report of The North American Menopause Society", Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010), 2011, pp.18, 732~753
- Li N, "Soy and isoflavone consumption and multiple health outcomes : umbrella review of systematic reviews and meta-analyses of observational studies and randomized trials in humans", Mol Nutr Food Res, 64, pp.e1900751~ (2020)
- Thomas AJ, "Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause : a systematic review", Maturitas, 78, pp.263~276 (2014)
- Chen LR, "Isoflavone supplements for menopausal women : a systematic review", Nutrients, 11, pp.E2649~ (2019)
- James W. Daily, "Equol Decreases Hot Flashes in Postmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Clinical Trials", Journal of Medicinal Food, 22(2), pp.127~139 (2019), 한국식품영양과학회[DOI]
- Ghazanfarpour M, "Topical administration of isoflavones for treatment of vaginal symptoms in postmenopausal women : a systematic review of randomised controlled trials", J Obstet Gynaecol, 35, pp.783~787 (2015)
- Brink E, "Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study", Am J Clin Nutr, 87, pp.761~770 (2008)
- Ryan-Borchers TA, "Soy isoflavones modulate immune function in healthy postmenopausal women", Am J Clin Nutr, 83, pp.1118~1125 (2006)
- Tai TY, "The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss : a 2-year randomized double-blind placebo-controlled study", Osteoporos Int, 23, pp.1571~1580 (2012)
- Charles C, "Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women", Menopause, 16, pp.395~400 (2009)
- Chilibeck PD, "Effect of exercise training combined with isoflavone supplementation on bone and lipids in postmenopausal women : a randomized clinical trial", J Bone Miner Res, 28, pp.780~793 (2013)
- Basaria S, "Effect of highdose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women", J Endocrinol Invest, 32, pp.150~155 (2009)
- Levis S, "Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms : a randomized, double-blind trial", Arch Intern Med, 171, pp.1363~1369 (2011)
- Valentine JC, "How many studies do you need? A primer on statistical power for meta-analysis (vol 35, pg 215, 2010)", J Educ Behav Stat, 35, pp.375~ (2010)
- Weare K, "Mental health promotion and problem prevention in schools: what does the evidence say?", Health Promot Int, 26(Suppl 1), pp.i29~i69 (2011)
